Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sven N Reske

Showing results (71-80 of 89) with videos related to

Pageof 9
Sort By:
British Journal of Haematology|August 4, 2004
CD34 cell selection of peripheral blood progenitor cells using the CliniMACS device for allogeneic transplantation: clinical results in 102 patientsMark Ringhoffer, Markus Wiesneth, Stephanie Harsdorf, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 14, 2007
Direct comparison of [18F]FDG PET/CT with PET alone and with side-by-side PET and CT in patients with malignant melanomaFelix M Mottaghy, Cord Sunderkötter, Roland Schubert, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|August 4, 2011
New molecular markers for prostate tumor imaging: a study on 2-methylene substituted fatty acids as new AMACR inhibitorsAgnieszka Morgenroth, Elizaveta A Urusova, Cornelia Dinger, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 18, 2008
First demonstration of leukemia imaging with the proliferation marker 18F-fluorodeoxythymidineAndreas K Buck, Martin Bommer, Malik E Juweid, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 3, 2006
Anti-CD45 monoclonal antibody YAML568: A promising radioimmunoconjugate for targeted therapy of acute leukemiaGerhard Glatting, Marguerite Müller, Bernd Koop, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 29, 2009
Clinical value of 18F-fluorodihydroxyphenylalanine positron emission tomography/computed tomography (18F-DOPA PET/CT) for detecting pheochromocytomaMarkus Luster, Wolfram Karges, Katrin Zeich, et al.
European Journal of Nuclear Medicine and Molecular Imaging|July 21, 2010
131I/123I-metaiodobenzylguanidine (mIBG) scintigraphy: procedure guidelines for tumour imagingEmilio Bombardieri, Francesco Giammarile, Cumali Aktolun, et al.
Thyroid : Official Journal of the American Thyroid Association|May 11, 2010
Clinical value of 18-fluorine-fluorodihydroxyphenylalanine positron emission tomography/computed tomography in the follow-up of medullary thyroid carcinomaMarkus Luster, Wolfram Karges, Katrin Zeich, et al.
Nature Clinical Practice. Oncology|March 1, 2007
A 25-year-old woman with a gastric GIST and a PET-positive epicardial tumorVolker Kächele, Sandra Pauls, Felix M Mottaghy, et al.
Molecular Imaging and Biology|January 22, 2008
Performance of integrated FDG-PET/CT for differentiating benign and malignant lung lesions--results from a large prospective clinical trialSandra Pauls, Andreas K Buck, Gisela Halter, et al.
Pageof 9

Showing results (71-80 of 89) with videos related to

Sort By:
Pageof 9
British Journal of Haematology|August 4, 2004
CD34 cell selection of peripheral blood progenitor cells using the CliniMACS device for allogeneic transplantation: clinical results in 102 patientsMark Ringhoffer, Markus Wiesneth, Stephanie Harsdorf, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 14, 2007
Direct comparison of [18F]FDG PET/CT with PET alone and with side-by-side PET and CT in patients with malignant melanomaFelix M Mottaghy, Cord Sunderkötter, Roland Schubert, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|August 4, 2011
New molecular markers for prostate tumor imaging: a study on 2-methylene substituted fatty acids as new AMACR inhibitorsAgnieszka Morgenroth, Elizaveta A Urusova, Cornelia Dinger, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 18, 2008
First demonstration of leukemia imaging with the proliferation marker 18F-fluorodeoxythymidineAndreas K Buck, Martin Bommer, Malik E Juweid, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 3, 2006
Anti-CD45 monoclonal antibody YAML568: A promising radioimmunoconjugate for targeted therapy of acute leukemiaGerhard Glatting, Marguerite Müller, Bernd Koop, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 29, 2009
Clinical value of 18F-fluorodihydroxyphenylalanine positron emission tomography/computed tomography (18F-DOPA PET/CT) for detecting pheochromocytomaMarkus Luster, Wolfram Karges, Katrin Zeich, et al.
European Journal of Nuclear Medicine and Molecular Imaging|July 21, 2010
131I/123I-metaiodobenzylguanidine (mIBG) scintigraphy: procedure guidelines for tumour imagingEmilio Bombardieri, Francesco Giammarile, Cumali Aktolun, et al.
Thyroid : Official Journal of the American Thyroid Association|May 11, 2010
Clinical value of 18-fluorine-fluorodihydroxyphenylalanine positron emission tomography/computed tomography in the follow-up of medullary thyroid carcinomaMarkus Luster, Wolfram Karges, Katrin Zeich, et al.
Nature Clinical Practice. Oncology|March 1, 2007
A 25-year-old woman with a gastric GIST and a PET-positive epicardial tumorVolker Kächele, Sandra Pauls, Felix M Mottaghy, et al.
Molecular Imaging and Biology|January 22, 2008
Performance of integrated FDG-PET/CT for differentiating benign and malignant lung lesions--results from a large prospective clinical trialSandra Pauls, Andreas K Buck, Gisela Halter, et al.
Pageof 9